Molecular mechanisms of ligand–receptor interactions in transmembrane domain V of the α(2A)-adrenoceptor

Por Peltonen, Juha M, Nyrönen, Tommi, Wurster, Siegfried, Pihlavisto, Marjo, Hoffrén, Anna-Marja, Marjamäki, Anne, Xhaard, Henri, Kanerva, Liisa, Savola, Juha-Matti, Johnson, Mark S, Scheinin, Mika
Publicado em 2003

Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)

Por Nave, Stephane, Doody, Rachelle S., Boada, Mercè, Grimmer, Timo, Savola, Juha-Matti, Delmar, Paul, Pauly-Evers, Meike, Nikolcheva, Tania, Czech, Christian, Borroni, Edilio, Ricci, Benedicte, Dukart, Juergen, Mannino, Marie, Carey, Tracie, Moran, Emma, Gilaberte, Inma, Muelhardt, Nicoletta Milani, Gerlach, Irene, Santarelli, Luca, Ostrowitzki, Susanne, Fontoura, Paulo
Publicado no J Alzheimers Dis (2017)